Leukemic Transformation in Myeloproliferative Neoplasms: A Literature Review on Risk, Characteristics, and Outcome.
Yogarajah M, Tefferi A.
Mayo Clin Proc · review; journal article · DOI 10.1016/j.mayocp.2017.05.010 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för pipobroman. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
16 träffarAssociation of Vemurafenib and Pipobroman Enhances BRAF-CRAF Dimerization in Squamous Cell Carcinoma.
Cassius C, Pages C, Roux J, Lhote R, Lavocat R, Réa D, Bagot M, Mourah S, Battistella M, Lebbé C, Dumaz N.
J Invest Dermatol · letter; case reports · DOI 10.1016/j.jid.2015.12.047Treatment of polycythemia vera with hydroxyurea and pipobroman: final results of a randomized trial initiated in 1980.
Kiladjian JJ, Chevret S, Dosquet C, Chomienne C, Rain JD.
J Clin Oncol · multicenter study; randomized controlled trial; journal article · DOI 10.1200/jco.2011.36.0792Pipobroman gets regulatory approval outside Germany.
Tsamaloukas AG.
Dtsch Arztebl Int · letter · DOI 10.3238/arztebl.2008.0071d[Multiples squamous cell carcinomas during treatment with pipobroman].
Tchen T, Durlach A, Bernard P, Grange F.
Ann Dermatol Venereol · letter; case reports · DOI 10.1016/s0151-9638(07)89272-6Long-term incidence of hematological evolution in three French prospective studies of hydroxyurea and pipobroman in polycythemia vera and essential thrombocythemia.
Kiladjian JJ, Rain JD, Bernard JF, Briere J, Chomienne C, Fenaux P.
Semin Thromb Hemost · comparative study; review; journal article · DOI 10.1055/s-2006-942762Del(5q) and MLL amplification in homogeneously staining region in acute myeloblastic leukemia: a recurrent cytogenetic association.
Herry A, Douet-Guilbert N, Guéganic N, Morel F, Le Bris MJ, Berthou C, De Braekeleer M.
Ann Hematol · research support, non-u.s. gov't; journal article; case reports · DOI 10.1007/s00277-005-0059-zLong-term follow-up of young patients with essential thrombocythemia treated with pipobroman.
Passamonti F, Rumi E, Malabarba L, Arcaini L, Orlandi E, Brusamolino E, Pascutto C, Cazzola M, Lazzarino M.
Ann Hematol · journal article · DOI 10.1007/s00277-004-0882-7Treatment of polycythemia vera and essential thrombocythemia: the role of pipobroman.
Passamonti F, Lazzarino M.
Leuk Lymphoma · review; journal article · DOI 10.3109/10428190309178768Long-term outcomes of polycythemia vera patients treated with pipobroman as initial therapy.
Kiladjian JJ, Gardin C, Renoux M, Bruno F, Bernard JF.
Hematol J · clinical trial; multicenter study; journal article · DOI 10.1038/sj.thj.6200250Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis.
Passamonti F, Malabarba L, Orlandi E, Pascutto C, Brusamolino E, Astori C, Baratè C, Canevari A, Corso A, Bernasconi P, Cazzola M, Lazzarino M.
Br J Haematol · research support, non-u.s. gov't; journal article · DOI 10.1046/j.0007-1048.2002.03367.xBone marrow aplasia after pipobroman: an immune-mediated mechanism?
Triffet A, Straetmans N, Ferrant A.
Br J Haematol · letter; review; case reports · DOI 10.1046/j.1365-2141.2001.03138-4.xEfficacy of pipobroman in the treatment of polycythemia vera: long-term results in 163 patients.
Passamonti F, Brusamolino E, Lazzarino M, Baraté C, Klersy C, Orlandi E, Canevari A, Castelli G, Merante S, Bernasconi C.
Haematologica · journal article[Acute liver disease during treatment with pipobroman and allopurinol].
Paitel JF, Trechot P, Stockemer V, Dorvaux V, Lederlin P.
Presse Med · letter; case reportsEvaluation of two antineoplastic agents, PIPOBROMAN (vercyte) and thioguanine.
Författaruppgift saknas
JAMA · journal article · DOI 10.1001/jama.1967.03120200097020Pipobroman (Vercyte) - a new antineoplastic drug.
Författaruppgift saknas
Med Lett Drugs Ther · journal article